Cargando…
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients
OBJECTIVE: The gut microbiota has been proposed as an interesting therapeutic target for metabolic disorders. Inulin as a prebiotic has been shown to lessen obesity and related diseases. The aim of the current study was to investigate whether preintervention gut microbiota characteristics determine...
Autores principales: | Rodriguez, Julie, Hiel, Sophie, Neyrinck, Audrey M, Le Roy, Tiphaine, Pötgens, Sarah A, Leyrolle, Quentin, Pachikian, Barbara D, Gianfrancesco, Marco A, Cani, Patrice D, Paquot, Nicolas, Cnop, Miriam, Lanthier, Nicolas, Thissen, Jean-Paul, Bindels, Laure B, Delzenne, Nathalie M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569399/ https://www.ncbi.nlm.nih.gov/pubmed/32041744 http://dx.doi.org/10.1136/gutjnl-2019-319726 |
Ejemplares similares
-
Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
por: Catry, Emilie, et al.
Publicado: (2018) -
Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
por: Le Roy, Tiphaine, et al.
Publicado: (2022) -
Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice
por: Abot, Anne, et al.
Publicado: (2021) -
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
por: Duparc, Thibaut, et al.
Publicado: (2017) -
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
por: Vandeputte, Doris, et al.
Publicado: (2017)